The global burden of blood cancers is steadily increasing, and among them, leukemia remains one of the most critical. According to recent research, the Leukemia Therapeutics Market is expected to grow from USD 18.2 billion in 2024 to USD 33.1 billion by 2033, at a CAGR of 7.3% during the forecast period (2025–2033). This projected growth reflects a convergence of medical innovation... https://alignstrategicimperative.com/industry/leukemia-therapeutics-market/